Rhone Ma Holdings Berhad (KLSE:RHONEMA)

Market Cap	157.74M +5.6%
Revenue (ttm)	223.68M +5.8%
Net Income	14.16M +15.1%
EPS	0.05 +15.4%
Shares Out	222.16M
PE Ratio	15.07
Forward PE	n/a
Dividend	0.03 (3.52%)
Ex-Dividend Date	Jan 16, 2026

Volume	140,000
Average Volume	106,690
Open	0.7000
Previous Close	n/a
Day's Range	0.7000 - 0.7100
52-Week Range	0.5800 - 0.7350
Beta	0.14
RSI	55.22
Earnings Date	Feb 20, 2026

About Rhone Ma Holdings Berhad

Rhone Ma Holdings Berhad, an investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia. The company provides diagnostic laboratory analysis and consultation services to veterinary, agriculture, and food industries; tests and diagnostics services for human healthcare; and veterinary advisory services. It also conducts research and development in biotechnology; distributes human healthcare and related products; wholesales and distributes pharmaceu...

• Industry: Pharmaceutical Preparations
• Founded: 2000
• Employees: 205
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: RHONEMA

Financial Performance

In 2025, Rhone Ma Holdings Berhad's revenue was 223.68 million, an increase of 5.81% compared to the previous year's 211.41 million. Earnings were 14.16 million, an increase of 15.07%.